James M. Markert

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas”.

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

New England Journal of Medicine(2021)10.1056/nejmoa2024947

N/A

4.7DataRank · unranked

323 citations

James M. Johnston, Asim K. Bag, Joshua D. Bernstock, Rong Li, Inmaculada Aban +23 more

Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy

Frontiers in Immunology(2024)10.3389/fimmu.2024.1375413

N/A

0.269DataRank · unranked

5 citations

Uksha Saini, Do‐Yeon Kim, Ilse Hernandez-Aguirre, Jack Hedberg, Alexia Martin +6 more

The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas

Frontiers in Surgery(2020)10.3389/fsurg.2020.00059

N/A

0DataRank · unranked

15 citations

R. Timothy Bentley, David K. Crossman, Jeremy B. Foote, Jennifer W. Koehler, James M. Markert +9 more

Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint Inhibition

Advances in Radiation Oncology(2020)10.1016/j.adro.2020.08.017

N/A

0DataRank · unranked

12 citations

Samuel Marcrom, Matthew H. Brown, Mayank P. Patel, James M. Markert, Kristen Riley +5 more

Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas

Neurosurgical FOCUS(2021)10.3171/2020.11.focus20844

N/A

0DataRank · unranked

42 citations

R. Timothy Bentley, David K. Crossman, Jeremy B. Foote, Jennifer W. Koehler, James M. Markert +8 more

Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance Results

Practical Radiation Oncology(2021)10.1016/j.prro.2020.10.013

N/A

0DataRank · unranked

39 citations

Matthew H. Brown, Evan Thomas, Christopher D. Willey, R Cardan, Elizabeth Covington +5 more

Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model

Scientific Reports(2021)10.1038/s41598-021-94887-x

N/A

0DataRank · unranked

28 citations

Hailey Houson, Jennifer Coleman, Jianmei W. Leavenworth, James M. Markert, Anna M. Wu +8 more

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab186

N/A

0DataRank · unranked

4 citations

Claudia R. Oliva, Christopher S. Coffey, Merit Cudkowicz, Robin Conwit, Anna Gudjonsdottir +28 more

Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model

Scientific Reports(2021)10.1038/s41598-021-00042-x

N/A

0DataRank · unranked

1 citations

Hailey Houson, Jennifer Coleman, Jianmei W. Leavenworth, James M. Markert, Anna M. Wu +8 more

Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2636

N/A

0DataRank · unranked

38 citations

Kevin A. Cassady, Justin C. Roth, Jennifer Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Assessing the Impact of Changes to USMLE Step 1 Grading on Evaluation of Neurosurgery Residency Applicants in the United States: A Program Director Survey

World Neurosurgery(2022)10.1016/j.wneu.2022.07.045

N/A

0DataRank · unranked

28 citations

Dagoberto Estévez-Ordoñez, Nicholas M. B. Laskay, Travis J. Atchley, Benjamin W. Saccomano, Andrew T. Hale +7 more

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1382

N/A

0DataRank · unranked

18 citations

Joshua D. Bernstock, Stacie K. Totsch, Sam E. Gary, Abbey Rocco, Li Nan +12 more

Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy

Cancers(2022)10.3390/cancers14030762

N/A

0DataRank · unranked

13 citations

Andee M. Beierle, Sara C. Hutchins, Raoud Marayati, Laura V. Bownes, Jerry E. Stewart +9 more

Racial and socioeconomic disparities in glioblastoma outcomes: A single‐center, retrospective cohort study

Cancer(2023)10.1002/cncr.34881

N/A

0DataRank · unranked

26 citations

Moaaz Abdelrashid, Elizabeth Coffee, Nicholas M. B. Laskay, Travis J. Atchley, Rati Chkheidze +6 more

Oncolytic virotherapies for pediatric tumors

Expert Opinion on Biological Therapy(2023)10.1080/14712598.2023.2245326

N/A

0DataRank · unranked

10 citations

Mohammad A. Hamo, Dagoberto Estévez-Ordoñez, Nicholas M.B. Laskay, Travis J. Atchley, James M. Johnston +2 more

Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain Metastases

Neurosurgery(2023)10.1227/neu.0000000000002585

N/A

0DataRank · unranked

9 citations

Samuel Marcrom, Mayank P. Patel, Richard A. Popple, Roman Travis, Andrew M. McDonald +7 more

Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

(2023)10.1158/1078-0432.c.6531350

N/A

0DataRank · unranked

0 citations

Kevin A. Cassady, Justin C. Roth, Jennifer N. Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

(2023)10.1158/1078-0432.c.6531350.v1

N/A

0DataRank · unranked

0 citations

Kevin A. Cassady, Justin C. Roth, Jennifer N. Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma

Journal of Clinical Investigation(2024)10.1172/jci163452

N/A

0DataRank · unranked

68 citations

Michael C. Brown, Zachary J. Reitman, Joshua D. Bernstock, James M. Markert, Gregory K. Friedman +4 more

[89Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models

Theranostics(2024)10.7150/thno.89206

N/A

0DataRank · unranked

16 citations

Yun Lü, Jennifer C. Clements, Patrick N. Song, Shannon E. Lynch, Alessandro Mascioni +9 more

Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03818-y

N/A

0DataRank · unranked

6 citations

Janet R. Julson, Hooper R. Markert, Nazia Nazam, Swatika Butey, Jerry E. Stewart +5 more

Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma

Nature Communications(2025)10.1038/s41467-024-55455-9

N/A

0DataRank · unranked

22 citations

Sadashib Ghosh, Shamza Manzoor, Li Xin Li, Monica M. Moran, Jennifer C. Clements +4 more

IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity

Nature Communications(2025)10.1038/s41467-025-58911-2

N/A

0DataRank · unranked

12 citations

Matthew P. Mullarkey, Sara A. Murphy, Joshua C. Anderson, Vasanta Putluri, Abu Hena Mostafa Kamal +12 more

Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery

World Neurosurgery(2025)10.1016/j.wneu.2024.123595

N/A

0DataRank · unranked

11 citations

Mihaela Stavarache, Ibrahim Tekedereli, Michael G. Kaplitt, James M. Markert, Nicholas Erickson

The effect of antidepressants on glioblastoma survival: A systematic review and meta-analysis

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf075

N/A

0DataRank · unranked

5 citations

Mohammad Hamo, Travis J. Atchley, Burt Nabors, James M. Markert, Dagoberto Estévez-Ordoñez +1 more

Comparison of 5-aminolevulinic acid and MMP-14 targeted peptide probes in preclinical models of GBM

Theranostics(2025)10.7150/thno.107210

N/A

0DataRank · unranked

2 citations

Tingting Dai, Ke Jiang, Jennifer C. Clements, Kaixiang Zhou, Carlos Gallegos +8 more

Preoperative Stereotactic Radiosurgery for Brain Metastases: A Phase 1 Dose Escalation Study Demonstrating Reduced Leptomeningeal Disease

Advances in Radiation Oncology(2025)10.1016/j.adro.2025.101882

N/A

0DataRank · unranked

2 citations

James M. Markert, Kristen Riley, Christopher D. Willey, Samuel Marcrom, Richard A. Popple +3 more

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

Nature Communications(2020)10.1038/s41467-020-18189-y

N/A

0DataRank · unranked

169 citations

Marat S. Pavlyukov, Daisuke Yamashita, Sadashib Ghosh, Heejin Cho, Noritaka Kagaya +17 more

Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms

Scientific Reports(2025)10.1038/s41598-025-98588-7

N/A

0DataRank · unranked

0 citations

Janet R. Julson, Michael H. Erwin, Hooper R. Markert, Larua V Bownes, Jerry E. Stewart +6 more

Efficacy of osimertinib against EGFRvIII+ glioblastoma

Oncotarget(2020)10.18632/oncotarget.27599

N/A

0DataRank · unranked

57 citations

Shawn G. Kwatra, Cory Nanni, Callie Roberts, S. Phillips, Sarah Nullmeyergh +13 more